Aarti Pharmalabs Fundamental Analysis
AARTIPHARM
968.514.75 (1.55%)
Last updated on 1 Oct, 2026 | 15:54 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Aarti Pharmalabs Fundamentals
P/E Ratio
41.11
P/B Ratio
4
Div. Yield
0.36
Sector P/E
42.73
Sector P/B
3.57
Sec. Div. Yield
0.51
Aarti Pharmalabs Fundamentals is currently trading with a P/E Ratio of 41.11, compared to the sector average of 42.73. Its P/B Ratio stands at 4, while the sector’s is 3.57. In terms of returns, the stock offers a Dividend Yield of 0.36%, which is than the sector’s 0.51%.
Aarti Pharmalabs Score Card
Price
Expensive
Growth
Good
Quality
Average
Management
Good
On its scorecard, Aarti Pharmalabs reflects: Price – Expensive, Growth – Good, Quality – Average, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in AARTIPHARM
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in AARTIPHARM
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade